Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update
23 Abril 2024 - 3:05PM
Business Wire
Arcus Biosciences (NYSE:RCUS), a clinical-stage, global
biopharmaceutical company focused on developing differentiated
molecules and combination therapies for people with cancer,
announced that its management team will host a conference call and
webcast on Wednesday, May 8th, 2024 at 1:30 PM PT / 4:30 PM ET to
discuss details of the Company’s financial results and pipeline
update for the quarter ended March 31st, 2024.
Investors interested in listening to the conference call may do
so by dialing (404) 975-4839 (local) or (833) 470-1428 (toll-free),
using Access Code: 034427. To access the live webcast and
accompanying slide presentation, please visit the “Investors &
Media” section of the Arcus Biosciences website at
www.arcusbio.com. A replay of the webcast will be available
following the live event.
About Arcus Biosciences
Arcus Biosciences is a clinical-stage, global biopharmaceutical
company developing differentiated molecules and combination
medicines for people with cancer. In partnership with industry
collaborators, patients and physicians around the world, Arcus is
expediting the development of first- or best-in-class medicines
against well-characterized biological targets and pathways and
studying novel, biology-driven combinations that have the potential
to help people with cancer live longer. Founded in 2015, the
company has expedited the development of multiple investigational
medicines into clinical studies, including new combination
approaches that target TIGIT, PD-1, the adenosine axis (CD73 and
dual A2a/A2b receptor), HIF-2a, CD39 and AXL. For more information
about Arcus Biosciences’ clinical and preclinical programs, please
visit www.arcusbio.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240423021977/en/
Investor Inquiries Pia Eaves VP of Investor Relations
& Strategy (617) 459-2006 peaves@arcusbio.com
Media Inquiries Holli Kolkey VP of Corporate
Communications (650) 922-1269 hkolkey@arcusbio.com
Arcus Biosciences (NYSE:RCUS)
Gráfica de Acción Histórica
De Feb 2025 a Mar 2025
Arcus Biosciences (NYSE:RCUS)
Gráfica de Acción Histórica
De Mar 2024 a Mar 2025
